Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
Company Announcements

Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference

Alpha Tau Medical Ltd (DRTS) has released an update.

Alpha Tau Medical Ltd., a pioneer in alpha-radiation cancer therapy with its Alpha DaRT™ technology, has announced that CFO Raphi Levy will present at the Jefferies Global Healthcare Conference in New York on June 5th, 2024. The company, founded in 2016, specializes in a novel treatment aimed at solid tumors that minimizes damage to surrounding healthy tissues. Investors will have the opportunity for one-on-one meetings with Mr. Levy during the conference.

For further insights into DRTS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAlpha Tau’s Alpha DaRT Gains FDA Study Approval
GlobeNewswireAlpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
TheFlyAlpha Tau announces FDA approval of IDE to initiate study of Alpha DaRT
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App